Find a Clinical Trial

Filter

Conditions treated
Department
Gender
Showing 11 - 12 out of 12
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
medical-cross
Breast cancer
user
All genders
person-wave 18+
world
Recruiting now
info
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Learn more
BCL Study
medical-cross
Breast cancer
user
Female
person-wave 18+
world
Recruiting now
info
Department of Surgery
Learn more